Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Pharma

At opioid racketeering trial, defense puts blame on government’s star witness

By Jonathan Saltzman — Boston GlobeApril 5, 2019

Reprints
John Kapoor
Insys Therapeutics founder John Kapoor in 2017. Ross D. Franklin/AP

At opioid racketeering trial, defense puts blame on government’s star witness

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Saltzman — Boston Globe

Tags

CVS warns PBM reforms ‘could lead to higher costs’
CVS warns PBM reforms ‘could lead to higher costs’
Lured by a bigger payday, a medical device maker…
Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted…
What does generative AI mean for health care? We…
What does generative AI mean for health care? We asked the experts
CVS warns PBM reforms ‘could lead to higher costs’
CVS warns PBM reforms ‘could lead to higher costs’
Pharmalittle: Appeals court rules Purdue can shield Sacklers from…
Pharmalittle: Appeals court rules Purdue can shield Sacklers from lawsuits; chemo shortage blamed on drugmakers’ lack…
Sacklers win appeal that shields them from opioid lawsuits,…
Sacklers win appeal that shields them from opioid lawsuits, clearing way for bankruptcy settlement

Recommended Stories